Anna M. Miglietta
Cosenza, 87100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors.
Journal: Journal of translational medicine
Published: August 06, 2025
Integrating trajectory inference and self-explainable predictive models to explore cell state transitions in breast cancer at single-cell resolution.
Journal: Frontiers in bioinformatics
Published: July 24, 2025
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC).
Journal: Journal of translational medicine
Published: May 22, 2025
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis.
Journal: Journal of translational medicine
Published: July 31, 2024
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients.
Journal: Journal of translational medicine
Published: May 29, 2024
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 19, 2024
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway.
Journal: Cell death discovery
Published: May 10, 2023
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 24, 2023
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells.
Journal: Cells
Published: July 01, 2022
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells.
Journal: Journal of translational medicine
Published: April 15, 2022
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer-associated fibroblasts.
Journal: Clinical and translational medicine
Published: March 31, 2021
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs).
Journal: Journal of experimental & clinical cancer research : CR
Published: July 03, 2020
Last Updated: 09/26/2026